Compass Research Phase 1, Llc — Orlando, Florida

Compass Research Phase 1, Llc is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Compass Research Phase 1, Llc has participated in 4 clinical trials.

Therapeutic areas: Type 1 Diabetes Mellitus, Hyperkalemia, Chronic Kidney Disease.

Sponsors: AstraZeneca, ZS Pharma, Inc., Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orlando

Browse all research sites in Florida · View every site in Orlando

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Research Phase 1, Llc?

Compass Research Phase 1, Llc has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Research Phase 1, Llc conducted?

Compass Research Phase 1, Llc has 4 clinical trials on record. Their work covers Type 1 Diabetes Mellitus, Hyperkalemia, Chronic Kidney Disease.

Is Compass Research Phase 1, Llc accredited by Crixeo Clinical Trials?

Compass Research Phase 1, Llc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Research Phase 1, Llc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.